Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates.

Acosta-Torres S, Murdock T, Matsuno R, Beavis AL, Stone RL, Wethington SL, Levinson K, Grumbine F, Ferriss JS, Tanner EJ, Fader AN.

Gynecol Oncol. 2020 Feb 18. pii: S0090-8258(20)30103-7. doi: 10.1016/j.ygyno.2020.02.008. [Epub ahead of print]

PMID:
32085863
2.

The impact of an enhanced recovery after minimally invasive surgery program on opioid use in gynecologic oncology patients undergoing hysterectomy.

Weston E, Noel M, Douglas K, Terrones K, Grumbine F, Stone R, Levinson K.

Gynecol Oncol. 2020 Feb 11. pii: S0090-8258(20)30094-9. doi: 10.1016/j.ygyno.2020.01.041. [Epub ahead of print]

PMID:
32059864
3.

A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).

Trimble CL, Levinson K, Maldonado L, Donovan MJ, Clark KT, Fu J, Shay ME, Sauter ME, Sanders SA, Frantz PS, Plesa M.

Gynecol Oncol. 2020 Jan 28. pii: S0090-8258(19)31865-7. doi: 10.1016/j.ygyno.2019.12.035. [Epub ahead of print]

PMID:
32005582
4.

Laparoscopic surgical access in morbidly obese women undergoing endometrial cancer surgery: Repurposing the left upper quadrant approach.

Varghese A, Peijnenburg E, Stone RL, Wethington SL, Levinson KL, Beavis A, Yen TT, Tanner EJ, Fader AN.

Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:56-59. doi: 10.1016/j.ejogrb.2019.11.007. Epub 2019 Nov 8.

PMID:
31734624
5.

Lower Genital Tract Dysplasia in Female Solid Organ Transplant Recipients.

Thimm MA, Rositch AF, VandenBussche C, McDonald L, Garonzik Wang JM, Levinson K.

Obstet Gynecol. 2019 Aug;134(2):385-394. doi: 10.1097/AOG.0000000000003378.

PMID:
31306332
6.

Immunotherapy in Gynecologic Cancers: What We Know Now and Where We Are Headed.

Levinson K, Dorigo O, Rubin K, Moore K.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:e126-e140. doi: 10.1200/EDBK_237967. Epub 2019 May 17. Review.

7.

Gynecologic cancer in HIV-positive women: a systematic review and meta-analysis.

Smith AJB, Varma S, Rositch AF, Levinson K.

Am J Obstet Gynecol. 2019 Sep;221(3):194-207.e5. doi: 10.1016/j.ajog.2019.02.022. Epub 2019 Feb 13.

PMID:
30771344
8.

Reasons for Lack of HPV Vaccine Initiation in NIS-Teen Over Time: Shifting the Focus From Gender and Sexuality to Necessity and Safety.

Beavis A, Krakow M, Levinson K, Rositch AF.

J Adolesc Health. 2018 Nov;63(5):652-656. doi: 10.1016/j.jadohealth.2018.06.024.

PMID:
30348283
9.

Narcotics reduction, quality and safety in gynecologic oncology surgery in the first year of enhanced recovery after surgery protocol implementation.

Bergstrom JE, Scott ME, Alimi Y, Yen TT, Hobson D, Machado KK, Tanner EJ 3rd, Fader AN, Temkin SM, Wethington S, Levinson K, Sokolinsky S, Lau B, Stone RL.

Gynecol Oncol. 2018 Jun;149(3):554-559. doi: 10.1016/j.ygyno.2018.04.003. Epub 2018 Apr 13.

PMID:
29661495
10.

Quantitative Thresholds Enable Accurate Identification of Clostridium difficile Infection by the Luminex xTAG Gastrointestinal Pathogen Panel.

Leal SM Jr, Popowitch EB, Levinson KJ, John TM, Lehman B, Rios MB, Gilligan PH, Miller MB.

J Clin Microbiol. 2018 May 25;56(6). pii: e01885-17. doi: 10.1128/JCM.01885-17. Print 2018 Jun.

11.

A 61-year-old man with erythematous forearm papules three months after liver transplantation.

Ayrapetyan M, Googe PB, Jolly P, Levinson K, Popowitch E, Lachiewicz AM.

Transpl Infect Dis. 2018 Jun;20(3):e12869. doi: 10.1111/tid.12869. Epub 2018 Mar 25.

12.

Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers.

Bergstrom J, Aloisi A, Armbruster S, Yen TT, Casarin J, Leitao MM Jr, Tanner EJ, Matsuno R, Machado KK, Dowdy SC, Soliman PT, Wethington SL, Stone RL, Levinson KL, Fader AN.

Gynecol Oncol. 2018 Mar;148(3):480-484. doi: 10.1016/j.ygyno.2018.01.002. Epub 2018 Jan 12.

13.

Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination.

Baranova DE, Levinson KJ, Mantis NJ.

PLoS One. 2018 Jan 2;13(1):e0190026. doi: 10.1371/journal.pone.0190026. eCollection 2018.

14.

Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study.

Ricci S, Tergas AI, Long Roche K, Fairbairn MG, Levinson KL, Dowdy SC, Bristow RE, Lopez M, Slaughter K, Moore K, Fader AN.

Gynecol Oncol Rep. 2017 Nov 15;22:100-104. doi: 10.1016/j.gore.2017.11.006. eCollection 2017 Nov.

15.

Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer.

Tanner E, Puechl A, Levinson K, Havrilesky LJ, Sinno A, Secord AA, Fader AN, Lee PS.

Gynecol Oncol. 2017 Dec;147(3):535-540. doi: 10.1016/j.ygyno.2017.10.020. Epub 2017 Oct 19.

PMID:
29056441
16.

Gynecologic cancer in HIV-infected women: treatment and outcomes in a multi-institutional cohort.

Levinson KL, Riedel DJ, Ojalvo LS, Chan W, Angarita AM, Fader AN, Rositch AF.

AIDS. 2018 Jan 14;32(2):171-177. doi: 10.1097/QAD.0000000000001664.

17.

Outcomes Associated With a Five-Point Surgical Site Infection Prevention Bundle in Women Undergoing Surgery for Ovarian Cancer.

Lippitt MH, Fairbairn MG, Matsuno R, Stone RL, Tanner EJ 3rd, Wick EC, Angarita AC, Roche KL, Levinson KL, Bergstrom JE, Sinno AK, Curless MS, Wethington S, Temkin SM, Efron J, Hobson D, Fader AN.

Obstet Gynecol. 2017 Oct;130(4):756-764. doi: 10.1097/AOG.0000000000002213.

PMID:
28885412
18.

The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.

Tanner EJ, Ojalvo L, Stone RL, Levinson K, Temkin SM, Murdock T, Vang R, Sinno AK, Fader AN.

Int J Gynecol Cancer. 2017 Sep;27(7):1416-1421. doi: 10.1097/IGC.0000000000001047.

PMID:
30814241
19.

Performance of ovarian cyst fluid fine-needle aspiration cytology.

Zhou AG, Levinson KL, Rosenthal DL, VandenBussche CJ.

Cancer Cytopathol. 2018 Feb;126(2):112-121. doi: 10.1002/cncy.21911. Epub 2017 Aug 21.

20.

Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?

Fader AN, Bergstrom J, Jernigan A, Tanner EJ 3rd, Roche KL, Stone RL, Levinson KL, Ricci S, Wethingon S, Wang TL, Shih IM, Yang B, Zhang G, Armstrong DK, Gaillard S, Michener C, DeBernardo R, Rose PG.

Gynecol Oncol. 2017 Oct;147(1):85-91. doi: 10.1016/j.ygyno.2017.07.127. Epub 2017 Jul 30.

PMID:
28768570
21.

Compliance with research standards within gynecologic oncology fellowship: A Gynecologic Oncology Fellowship Research Network (GOFRN) study.

Moulton LJ, Michener CM, Levinson K, Cobb L, Tseng J, Jernigan A.

Gynecol Oncol. 2017 Sep;146(3):647-652. doi: 10.1016/j.ygyno.2017.06.034. Epub 2017 Jul 8.

PMID:
28698010
22.

Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.

Geyer JT, Tam W, Liu YC, Chen Z, Wang SA, Bueso-Ramos C, Oak J, Arber DA, Hsi E, Rogers HJ, Levinson K, Bagg A, Hassane DC, Hasserjian RP, Orazi A.

Mod Pathol. 2017 Sep;30(9):1213-1222. doi: 10.1038/modpathol.2017.45. Epub 2017 May 26.

23.

Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.

Sinno AK, Li X, Thompson RE, Tanner EJ 3rd, Levinson KL, Stone RL, Temkin SM, Fader AN, Chi DS, Long Roche K.

Gynecol Oncol. 2017 Jun;145(3):493-499. doi: 10.1016/j.ygyno.2017.03.020. Epub 2017 Mar 30.

24.

Perioperative fluid status and surgical outcomes in patients undergoing cytoreductive surgery for advanced epithelial ovarian cancer.

Desale MG, Tanner EJ 3rd, Sinno AK, Angarita AA, Fader AN, Stone RL, Levinson KL, Bristow RE, Roche KL.

Gynecol Oncol. 2016 Oct 28. pii: S0090-8258(16)31501-3. doi: 10.1016/j.ygyno.2016.10.027. [Epub ahead of print]

PMID:
28029449
25.

Preinvasive and Invasive Cervical Adenocarcinoma: Preceding Low-Risk or Negative Pap Result Increases Time to Diagnosis.

Moukarzel LA, Angarita AM, VandenBussche C, Rositch A, Thompson CB, Fader AN, Levinson K.

J Low Genit Tract Dis. 2017 Apr;21(2):91-96. doi: 10.1097/LGT.0000000000000286.

26.

Brief Report: A Second Primary Endodermal Sinus Tumor 9 Years after Initial Diagnosis.

Moukarzel LA, Levinson K, Grumbine FC.

J Pediatr Adolesc Gynecol. 2017 Apr;30(2):259-261. doi: 10.1016/j.jpag.2016.10.012. Epub 2016 Nov 4.

PMID:
27818263
27.
28.

Reducing overtreatment: A comparison of lymph node assessment strategies for endometrial cancer.

Sinno AK, Peijnenburg E, Fader AN, Temkin SM, Stone R, Levinson K, Murdock T, Tanner EJ.

Gynecol Oncol. 2016 Nov;143(2):281-286. doi: 10.1016/j.ygyno.2016.08.323. Epub 2016 Aug 24.

PMID:
27568279
29.

Laparoscopic Abdominal Access Using a Modified Left Upper Quadrant Technique in Morbidly Obese Women Undergoing Gynecologic Surgery.

Peijnenburg E, Tanner EJ, Stone RL, Levinson KL, Nickles Fader A.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S197. doi: 10.1016/j.jmig.2015.08.716. Epub 2015 Oct 15. No abstract available.

PMID:
27679022
30.

Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology.

Wilbur MB, Mannschreck DB, Angarita AM, Matsuno RK, Tanner EJ, Stone RL, Levinson KL, Temkin SM, Makary MA, Leung CA, Deutschendorf A, Pronovost PJ, Brown A, Fader AN.

Gynecol Oncol. 2016 Dec;143(3):604-610. doi: 10.1016/j.ygyno.2016.09.020. Epub 2016 Sep 21.

PMID:
27665313
31.

The Use of "Optimal Cytoreduction" Nomenclature in Ovarian Cancer Literature: Can We Move Toward a More Optimal Classification System?

Angarita AM, Stone R, Temkin SM, Levinson K, Fader AN, Tanner EJ.

Int J Gynecol Cancer. 2016 Oct;26(8):1421-7. doi: 10.1097/IGC.0000000000000796.

PMID:
27575626
32.

Disparities in Surgical Care Among Women With Endometrial Cancer.

Mannschreck D, Matsuno RK, Moriarty JP, Borah BJ, Dowdy SC, Tanner EJ 3rd, Makary MA, Stone RL, Levinson KL, Temkin SM, Fader AN.

Obstet Gynecol. 2016 Sep;128(3):526-34. doi: 10.1097/AOG.0000000000001567.

PMID:
27500330
33.

Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination.

Beavis AL, Levinson KL.

Front Oncol. 2016 Feb 1;6:19. doi: 10.3389/fonc.2016.00019. eCollection 2016. Review.

34.

Concordance of Expert Consultation Diagnoses in the Review of Pelvic Washing Specimens.

Banet N, Levinson KL, VandenBussche CJ.

Acta Cytol. 2015;59(6):452-6. doi: 10.1159/000443715. Epub 2016 Jan 28.

PMID:
26820245
35.

Intimate Partner Violence and Barriers to Cervical Cancer Screening: A Gynecologic Oncology Fellow Research Network Study.

Levinson KL, Jernigan AM, Flocke SA, Tergas AI, Gunderson CC, Huh WK, Wilkinson-Ryan I, Lawson PJ, Fader AN, Belinson JL.

J Low Genit Tract Dis. 2016 Jan;20(1):47-51. doi: 10.1097/LGT.0000000000000153.

36.

Lymphopenia and its association with survival in patients with locally advanced cervical cancer.

Wu ES, Oduyebo T, Cobb LP, Cholakian D, Kong X, Fader AN, Levinson KL, Tanner EJ 3rd, Stone RL, Piotrowski A, Grossman S, Roche KL.

Gynecol Oncol. 2016 Jan;140(1):76-82. doi: 10.1016/j.ygyno.2015.11.013. Epub 2015 Nov 11.

37.

Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer.

Tanner EJ, Sinno AK, Stone RL, Levinson KL, Long KC, Fader AN.

Gynecol Oncol. 2015 Sep;138(3):542-7. doi: 10.1016/j.ygyno.2015.06.024. Epub 2015 Jun 19.

PMID:
26095896
38.

Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.

Levinson KJ, Giffen SR, Pauly MH, Kim DH, Bohorov O, Bohorova N, Whaley KJ, Zeitlin L, Mantis NJ.

J Immunol Methods. 2015 Jul;422:111-7. doi: 10.1016/j.jim.2015.04.001. Epub 2015 Apr 9.

39.

Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.

Levinson KJ, De Jesus M, Mantis NJ.

Infect Immun. 2015 Apr;83(4):1674-83. doi: 10.1128/IAI.02856-14. Epub 2015 Feb 9.

40.

A Patient With Parenteral Nutrition-Dependent Short Bowel Syndrome and Cardiovascular Disease With 4-Year Exposure to Teduglutide.

Compher C, Levinson KB, Cambor CL, Stoner N, Boullata JI, Piarulli A, Kinosian B.

JPEN J Parenter Enteral Nutr. 2016 Jul;40(5):725-9. doi: 10.1177/0148607114566466. Epub 2015 Jan 7.

PMID:
25567782
41.

Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer: a multi-institutional study.

Escobar PF, Levinson KL, Magrina J, Martino MA, Barakat RR, Fader AN, Leitao MM Jr.

Gynecol Oncol. 2014 Aug;134(2):253-6. doi: 10.1016/j.ygyno.2014.05.007. Epub 2014 May 16.

PMID:
24844594
42.

Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies.

Tan AR, Dowlati A, Stein MN, Jones SF, Infante JR, Bendell J, Kane MP, Levinson KT, Suttle AB, Burris HA 3rd.

Br J Cancer. 2014 May 27;110(11):2647-54. doi: 10.1038/bjc.2014.233. Epub 2014 May 6.

43.

The Peru Cervical Cancer Screening Study (PERCAPS): the design and implementation of a mother/daughter screen, treat, and vaccinate program in the Peruvian jungle.

Abuelo CE, Levinson KL, Salmeron J, Sologuren CV, Fernandez MJ, Belinson JL.

J Community Health. 2014 Jun;39(3):409-15. doi: 10.1007/s10900-013-9786-6.

44.

Evolving technologies in robotic surgery for minimally invasive treatment of gynecologic cancers.

Levinson KL, Auer M, Escobar PF.

Expert Rev Med Devices. 2013 Sep;10(5):603-10. doi: 10.1586/17434440.2013.827509. Review.

PMID:
24053253
45.

Feasibility and optimal dosage of indocyanine green fluorescence for sentinel lymph node detection using robotic single-site instrumentation: preclinical study.

Levinson KL, Mahdi H, Escobar PF.

J Minim Invasive Gynecol. 2013 Sep-Oct;20(5):691-6. doi: 10.1016/j.jmig.2013.03.013.

PMID:
24034538
46.

Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?

Ricci S, Giuntoli RL 2nd, Eisenhauer E, Lopez MA, Krill L, Tanner EJ 3rd, Gehrig PA, Havrilesky LJ, Secord AA, Levinson K, Frasure H, Celano P, Fader AN.

Gynecol Oncol. 2013 Dec;131(3):629-33. doi: 10.1016/j.ygyno.2013.08.037. Epub 2013 Sep 7.

PMID:
24016408
47.

Is sentinel lymph node dissection an appropriate standard of care for low-stage endometrial cancers? A review of the literature.

Levinson KL, Escobar PF.

Gynecol Obstet Invest. 2013;76(3):139-50. doi: 10.1159/000353897. Epub 2013 Aug 8. Review.

PMID:
23942330
48.

Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.

Mahdi H, Moslemi-Kebria M, Levinson KL, Gojayev A, Lockhart D, Ali-Fehmi R, Munkarah AR.

Int J Gynecol Cancer. 2013 Sep;23(7):1226-30. doi: 10.1097/IGC.0b013e3182856736.

PMID:
23736258
49.

The Peru Cervical Cancer Prevention Study (PERCAPS): the technology to make screening accessible.

Levinson KL, Abuelo C, Salmeron J, Chyung E, Zou J, Belinson SE, Wang G, Ortiz CS, Vallejos CS, Belinson JL.

Gynecol Oncol. 2013 May;129(2):318-23. doi: 10.1016/j.ygyno.2013.01.026. Epub 2013 Feb 4.

50.

The Peru cervical cancer prevention study (PERCAPS): community-based participatory research in Manchay, Peru.

Levinson KL, Abuelo C, Chyung E, Salmeron J, Belinson SE, Sologuren CV, Ortiz CS, Vallejos MJ, Belinson JL.

Int J Gynecol Cancer. 2013 Jan;23(1):141-7. doi: 10.1097/IGC.0b013e318275b007.

Supplemental Content

Loading ...
Support Center